VAT vs VAP: are we heading toward clarity or confusion?
Dallas
John
J
St. Louis, MO.
Kollef
Marin
M
St. Louis, MO. Electronic address: mkollef@im.wustl.edu.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D003937:Diagnosis, Differential; D019317:Evidence-Based Medicine; D006801:Humans; D015994:Incidence; D007362:Intensive Care Units; D053717:Pneumonia, Ventilator-Associated / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D012121:Respiration, Artificial / Q000009:adverse effects*; D012680:Sensitivity and Specificity; D014136:Tracheitis / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology
D000900:Anti-Bacterial Agents